Gapping up
News:
- QTTB +80.2% (36-Week Topline Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata)
- TCBK +5.3% (First Hawaiian to acquire TriCo Bancshares in all-stock deal; posts preliminary Q2 results)
- ARMP +4.9% (received agreement from the FDA on an Agreed Initial Pediatric Study Plan, which establishes the agreed regulatory framework for the future evaluation of AP-SA02)
- GFR +3.9% (to undertake a rights offering of its common shares)
- NOG +2.4% (reiterates 2026 production/capex outlook; boosts buyback authorization to about $243 mln)
- EVTL +2.4% (shares business update ahead of Farnborough International Airshow)
- MGM +2.4% (MGM (MGM) negotiating a possible deal with Barry Diller's People Inc. (PPLI) after Mr. Diller offered to buy MGM)
- CODI +1.9% (announces amendments to management services agreement reducing management costs and further strengthening shareholder alignment; reaffirms FY26 guidance )
- SSP +1.3% (reaches multi-year carriage deal with DIRECTV; 54 local stations restored)
- REZI +1.3% (to present strategy and financial framework as pure-play building technologies company at Investor Day; issues medium term guidance)
- GCO +1% (All three independent proxy advisory firms recommend Genesco shareholders vote "for" all nine of Genesco's directors)